In 2008, she co-founded WIN (Women In Innovation), an initiative supported by SCAI (Society of Cardiovascular Angiography and Interventions) to raise awareness of heart diseases in women. She is the Chair of the Scientific Committee of the European Association of Percutaneous Cardiovascular Interventions (EAPCI) Women and Italian Society of Interventional Cardiology (GISE).
She has published more than 320 published manuscripts. She is a Reviewer of several journals such as Am J Cardiol, EuroIntervention, and Italian Heart Journal. She is an editorial board member of Minerva Cardioangiologica and International Journal of Cardiology.
She has won multiple research awards including Thomas J. Linnemeier’s Spirit of Interventional Cardiology Young Investigator Award in 2006.
She is highly passionate about Cardiovascular Magnetic Resonance (CMR) education, training, and clinical care. She is the CEO of the Society for Cardiovascular Magnetic Resonance (SCMR). She has also excelled in other medical societies such as the European Association of Cardiovascular Imaging (EACVI) of the European Society of Cardiology (ESC), where she served as the Vice-Chair and then Chair of the CMR section.
She was an Honorary Senior Lecturer in Cardiology at the National Heart and Lung Institute (NHLI) of the Imperial College of London. She was also an Honorary CMR consultant at the Royal Brampton Hospital, London.
Her research interests are acute and chronic ischemic heaty disease, cardiac MRI, non-ischemic cardiomyopathies, heart failure, heart valve disease, and translational research.
She is an author of 3 published books, over 50 peer-reviewed papers and has delivered more than 100 lectures as an invited speaker.
His current work relates experimental research (using mouse models of atherosclerosis and thrombosis) to clinical studies in patients with myocardial infarction and acute heart failure as well as patients at the interface between cardiology and oncology.
He is now working as the Head of Department of Cardiology at the Rennes University since 2015. He is also the Vice-President of the medical board at Rennes University Hospital.
He serves as a Reviewer in various cardiology journals and is a board member of the European Heart Journal, EUROPACE, and Circulation. He has published more than 210 manuscripts and his Hirsch index (Web of Science) is 47.
He has been a Principal Investigator of several trials such as PROSPECT, B-LEFT, CHAMP, SEPTAL-CRT, ADAPTIVE-CRT, MORE CRT-MPP, and SMART-CRT.
He is a yearly lecturer at the Heart Rhythm Society (HRS), European Society of Cardiology (EUROPACE), and Emirates Society of Cardiology (ESC) meetings. He is an executive board member of the French Society of Cardiology since 2009 and the European Heart Rhythm Association (EHRA) since 2013.
His clinical specialties are atrial fibrillation, supraventricular tachycardia (non-AF), ventricular arrhythmias, and sudden cardiac death. His research interests include catheter ablation of atrial flutter, persistent AF and analysis of the underlying mechanism, and ablation strategies for atypical flutter.
He has been an editorial board member of medical journals such as Heart Rhythm Journal, Persian Heart Journal, Journal of Interventional Cardiac Electrophysiology, Journal of Arrhythmia, and Journal of Atrial Fibrillation. He was also a Reviewer of various other journals including Lancet, Cardiology, American Journal of Cardiology and European Heart Journal.
Prof Kaski’s research areas include mechanisms of rapid coronary artery disease progression, inflammatory and immunological mechanisms of atherosclerosis, microvascular angina, and biomarkers of cardiovascular risk. Prof Kaski has published over 400 papers in peer-review journals, over 200 invited papers in cardiology journals, and more than 130 book chapters. He has also edited six books on cardiovascular topics.
He earned his M.D. from the University of Vienna and completed his Fellowship Training in General Hospital in Vienna and Brigham and Women’s Hospital in Boston, United States. He has a board certificate in Cardiology, Internal Medicine, and Intensive Care Medicine from the Austrian Medical Chamber.
His major research interests are Acute Coronary Syndromes, STEMI networks, Antiplatelet Therapy, and Cardiovascular Interventional Registries.
He is the Vice President of the European Society of Cardiology (ESC) for 2018 – 2020, and past President of the Austrian Cardiological Society. He was a member of the editorial board of Journal for Cardiology in 2003 and EuroIntervention in 2005.
Dr. Roffi is the Chairman (Congress Programme Committee) of the European Society of Cardiology (ESC) 2019 and 2020. He is the past-Chairman of the scientific board of European Association of Percutaneous Cardiovascular Interventions (EAPCI) and a current scientific board member of the EuroPCR.
He has co-authored over 300 PubMed publications, 54 book chapters, and 3 books (edited). He has also written the ESC guidelines of peripheral artery disease (2011), non-cardiac surgery (2014), aortic diseases (2014), and was the chairman of the NSTEMI guidelines (2015).
His clinical and research fields of interest include acute coronary syndromes, antiplatelet therapy, coronary artery disease in diabetes, and carotid as well as peripheral interventions.
He is a member of the societies: Swiss Society of General Internal Medicine (SSMIG), Swiss Society of Cardiology (SSC) and Fellow of the American College of Cardiology (FACC) and Fellow of the European Society of Cardiology (FESC).
She is the Director of the research program Translational Electrophysiology, which was rewarded the prestigious VIDI-grant in 2018. She is a Principal Investigator of the Erasmus Center of Atrial Fibrillation. She is also the Scientific Leader of the Medical Delta Cardiac Arrhythmia Lab and Co-Founder of Atrial Fibrillation Innovation Platform (AFIP), a foundation aimed at co-creating innovative research in the area of AF together with doctors, patients, and researchers.
Her research topics include the study of catheter ablation of complex tachyarrhythmias in patients with congenital heart disease and catheter ablation in pediatric patients. She has been writing international guidelines on these topics since 2010. She has contributed to the guideline of various societies and associations including the European Society of Cardiology (ESC), European Heart Rhythm Association (EHRA), and Heart Rhythm Society (HRS).
She is a board member of the EHRA since 2015. She is also the editorial board member of the Netherlands Heart Journal and a medical advisor for pharmaceutical companies like Pharmacotherapy and Health Base.
Previous positions include Auxiliary Professor of Nutrition and Public Health at the University of Lisbon and Professor of Medical Statistics at the Higher Institute of Health Sciences Egas Moniz (ISCSEM) where he was also the Director of the scientific committee of the Nutrition course.
He obtained his MD in Clinical Research from the Toulouse II University in France. He also has a Ph.D. in Biochemistry, Ph.D. in Epidemiology, MSc in Physiopathology, and MSc in Medical Statistics.
His research interests include the distribution, determinants, and effects of cardiovascular risk factors in the population. He has published over 500 scientific papers on cardiovascular epidemiology. He has contributed to several ESC guidelines. He has also served as a clinical expert in various trials including the CoLaus study.
He is currently working as a Full Professor of Clinical Epidemiology at Utrecht University. He is the founder of Julius Center for Health Sciences and Primary Care, a division of the University Medical Center Utrecht (UMCU) and of Julius Clinical, an Academic Contract Research Organization where he serves as a Chief Scientific Officer. He also serves as the Chair of the Center for Circulatory Health at the UMCU governing cardiovascular patient care. Additionally, he is a Visiting Professor at the University of Malaya and the University of Sydney.
He has acted as a Principal investigator in many clinical trials relating to the prevention and treatment of heart diseases. He is the Senior Consulting Editor of the Journal European Journal of Preventive Cardiology and Editor-in-Chief of Global Heart.
Dr. Grobbee has published over 1,300 scientific papers chapters, and books, and has been ranked as a highly cited author by Web of Science with a Hirsch index of 151.
He is also the author of two published books: The Oxford Textbook of Heart Failure and the Oxford Specialist Handbook of Heart Failure. He is an editorial board of the peer-reviewed journal Biomarkers in Medicine and a clinical expert of the National Institute for Health and Care Excellence (NICE).
He is the Treasurer of the British Society for Heart Failure (BSH) and an Honorary Professor at the University of Glasgow.
He research interests include advanced heart failure, cardiac transplantation, mechanical circulatory support (artificial hearts), and complex device implantation (ICDs and CRT).
She received her M.D. from the Edinburgh University and post-doctoral training in Cardiology from the Glasgow Western Infirmary.
She specializes in the diagnosis and treatment of heart failure, specifically the epidemiology of left ventricular dysfunction and the role of biomarkers.
She is a board member of the world’s largest heart failure association, the Heart Failure Association (HFA) affiliated by the European Society of Cardiology (ESC). She is also a Clinical Lead of the National Heart Failure Audit (NHFA) of the British Society for Heaty Failure (BSH).
Greatest professional challenge: re-configuring a specialist critical care unit whilst simultaneously successfully bidding for extracorporeal membrane oxygenation commissioned services which are now the most successful in the UK. Greatest professional achievement: hopefully still to come. Susanna comes from a family of professional musicians, is a keen cellist, pianist, and bibliophile.
His clinical specialties are Interventional Cardiology, Coronary Artery Disease Chronic, Risk Factors and Prevention, e-Cardiology, and Valvular Heart Disease.
He is Member and Chair of the Guidelines Commission of the European Society of Cardiology. He has authored/co-authored over 320 publications in renowned journals. He was a co-initiator of REBIRTH – Hannover Medical School’s Cluster of Excellence. His research examines mechanisms leading to coronary disease and in particular to myocardial infarction as well as novel catheter-based diagnostic and therapeutic procedures of cardiovascular medicine.
She is currently working as a Consultant Cardiologist at the Leiden University Medical Center for the past 10 years. Her clinical interests are multimodality imaging in heart failure and valvular heart disease.
She is a Fellow of the European Society of Cardiology (ESC). She is also a part of the ESC guidelines committee and the task force of diabetes and dyslipidemia guidelines. Additionally, she is a board member of the European Association of Cardiovascular Imaging (EAVCI) and Chair of the scientific documents of the EAVCI. She is an Associate Editor of the journal: Circulation and the Journal of American Society of Echocardiography.
She has received research grants from several societies such as the Spanish Society of Cardiology and the European Society of Cardiology.
He earned his bachelor in Pharmaceutical Science from King Saud University in 2011. He then obtained his Ph.D. in Pharmacy from the University of Tennessee Health Science Center in 2015. He completed his residency training in Pharmacy Practice and Cardiovascular Pharmacy from the Brigham and Women’s Hospital in 2016-2017.
His research interests are Cardiovascular Clinical and Translational Research, Interventional Cardiovascular Pharmacotherapy Outcomes, Venous Thromboembolism Epidemiology and Outcomes, and Advanced Heart Failure Outcomes.
He earned his MD from the Arabian Gulf University in 1999, followed by Master of Advanced Studies in Clinical Research from the University of California in 2010.
He is a Fellow of both the American College of Cardiology and the European Society of Cardiology (FACC and FESC, respectively). He is also a Fellow of the Emory University Hospital (USA), a Fellow of the Henry Ford Institute (USA), and a Fellow of the University of Lausanne, Switzerland. Professor Sobhy is a Board Member of the Working Group of Interventional Cardiology, and an active member of the Middle East Focus of the American College of Cardiology being the vice president in 2012, he is the Governor and Founder of the American College of Cardiology (ACC chapter) since 2010 and of various advisory boards. He was Stent for Life (SFL) champion till 2015 and now he is Stent – save a life (SSL) Africa Committee Member. Also, he is the Middle East/Africa Representative to the Assembly of International Governors Steering Committee.
He earned his MBBS from King Saud University in 2006. He obtained his residency in internal medicine from The University of British Columbia and a residency in cardiology from the University of Toronto.
His clinical expertise are Heart Failure, Echocardiography, Clinical Cardiology, Chronic Heart Failure, Cardiomyopathies, Acute Heart Failure, Cardiac Imaging, Heart Transplantation, and Three-Dimensional Echocardiography.
After qualifying from the Arabian Gulf with first-degree Honors in 1996, he pursued postgraduate training in the United States. He did an internal medicine residency at Henry Ford Hospital, Michigan. Then Cardiology fellowship at Loma Linda University, California, and followed by an Interventional Cardiology fellowship at the University of Massachusetts. Additionally, he achieved an advanced training for peripheral endovascular interventions at Arizona Heart Hospital. He is also a diplomat in Health care management. He is a member of the board of Trustees at the British School of Bahrain.
Dr.Husam Noor plays a key role in educating the public, patients, and healthcare professionals across the Gulf States about coronary artery disease. He is on the scientific committee for the Gulf-PCR. He gives regular lectures at scientific meetings nationally and internationally. His main areas of interest include acute coronary syndrome and primary PCI. He has established the chronic total occlusion program. He leads the TAVI and appendage closure programs. He is active in clinical research and has been involved in international multicenter trials.
He received the Kingdom of Bahrain’s first-degree recognition and accomplishment award from his Majesty the King of Bahrain 2013.
He has published several publications in high impact journals such as Heart Views and the Saudi Journal of Anaesthesia.
Some of his research topics include ECG and Arrhythmia in Children, Cardioverter Defibrillator in Pediatric Patients, and Cardiac Device Implantation.
He is currently working as a Self-employed Interventional Cardiologist. He is also the Interim Chief Executive Officer of Clemenceau Medical Center. Some of his past work experiences include Part-time Consultant and Head of the Cardiac Centre at Dr. Sulaiman AL Habib Medical Group, Co-Founder of the Department of Cardiology at King Fahad Medical City, and Chairman of Cardiology at Kingdom Hospital and Consulting Clinics.
He is the President of the Saudi Arabian Interventional Cardiology Society (SACIS) since 2018.
Between 1993 – 1997 he did his residency in internal medicine at the University of Western Ontario, Canada, and received the American Board of Internal Medicine ( ABIM) in 1996 as well as the Canadian Board of Internal Medicine in 1997. He also received a fellowship from the Royal College of Physician and Surgeon of Canada ( FRCPC) in 1997 and became a Member of the American College of Physician ( MACP) as well. He did his Cardiology residency at Ottawa Heart Institute- Ottawa, Canada from 1997 – 2000.
In 2000, he had the Canadian Board of Cardiology and in the same year 2000, he also had the American Board of Cardiology and received a fellowship of the American College of Angiology (FACA). In 2003, he was awarded a fellowship of the American College of Cardiology ( FACC).
In 2008, he was awarded a fellowship of the European Society of Cardiology (FESC). In 2009, he was awarded also a fellowship of the American College of Physician ( FACP). In 2015, he was awarded a fellowship of the Society for Cardiovascular Angiography and Interventions(FSCAI).
He is a Vice president of the Kuwait Cardiac Society(KCS) a member of the Kuwait Heart Foundation. He is a Board member in the Gulf Heart Association (GHA) and General Secretary of Gulf interventional society(GIS).
During his clinical career, he has contributed to several Local and International Journal Publications. Dr. Akbar has chaired and presented more than 100 local and regional lectures related to his field of Cardiology.
In 1999 he moved to Ottawa, Canada where he did his residency in Cardiac surgery. After successfully obtaining his fellowship from the Royal College of Surgeons in Canada in Cardiac Surgery he started a clinical fellowship in Vascular and Endovascular Surgery in Ottawa, Canada. In 2007 he received his second fellowship, in Vascular Surgery from the Royal College of Surgeon in Canada. Dr. AlBlooshi returned to Zayed Military Hospital in 2007 where he was given a post of Consultant Cardiac Surgeon. In 2008 he was chosen as the chief of Cardiac Surgery. In the same year, he established the Division of Vascular Surgery.
In 2011 Dr. AlBlooshi has been assigned as the Chief of the Department of Surgery. In 2019 Dr. AlBlooshi was chosen as the Commander of Zayed Military Hospital. Dr. AlBlooshi continues to be an active Cardiac and Vascular Surgeon with participation in many local, regional, and international meetings in both disciplines. He is the recipient of the coveted Abu Dhabi Medical Excellence Award in 2013 and an editor for the Pan Arab Angiology Journal.
Before joining Cleveland Clinic Abu Dhabi, Dr. Edris was an Assistant Clinical Professor of Medicine at the David Geffen School of Medicine at UCLA, where he was part of a busy cardiology practice treating a spectrum of cardiovascular disease and performing a high-volume of interventional cardiology procedures. He was also involved in the training and education of UCLA Cardiology fellows.
He is trained in advanced coronary and structural heart disease interventions with a focus on minimally-invasive cardiac procedures, including percutaneous valve interventions such as transcatheter aortic valve replacement (TAVR) and mitral valve interventions. He is part of the Structural Heart team and has been involved in the evaluation and treatment of structural and valvular heart disease patients at Cleveland Clinic Abu Dhabi. His specialty expertise includes the treatment of ischemic heart disease, structural heart, and valve disease, invasive coronary imaging, cardiomyopathy, and congestive heart failure and coronary interventions.
Dr. Edris is certified by the American Board of Internal Medicine in the subspecialties of Cardiovascular Disease and Interventional Cardiology. He holds a Certification Board in Nuclear Cardiology. He is also a fellow of the American College of Cardiology and the Society for Cardiovascular Angiography and Interventions.
Dr. Edris has a special interest in transradial procedures and has performed thousands of cardiac diagnostic, as well as interventional procedures, using the transradial approach. His transradial research has led to improvements in the management of his patients. He has also been a principal investigator, or co-investigator, in several research studies. His articles and abstracts have been published in leading medical journals and he has written several book chapters in multiple medical textbooks covering topics in cardiovascular disease and interventional cardiology, as well as transcatheter valve disease interventions. Additionally, Dr. Edris has been invited to lecture at several international cardiology conferences.
He is a graduate of the University of California, Los Angeles. He received his medical degree from the University of California, Irvine School of Medicine, and continued his training with a residency in Internal Medicine and a fellowship in Cardiovascular Disease at the University of California, Irvine Medical Center. He then completed his fellowship in Interventional Cardiology at Tufts University School of Medicine, where he trained in complex coronary and structural interventions.
Dr. Edris enjoys spending his free time with his wife and two children. He and his family enjoy exploring the region and traveling.
Now he is a founding partner, medical director, and head of the cardiology department at the United Medical Centre, as well as an Associate Professor at Mohammed Bin Rashid University of Medicine and Health Sciences (MBRU).
He is a Middle East regional faculty member and a member of the American Heart Association since 2003 and he is a professional associate since 2010.
He is also a part of the final year’s cardiology faculty doctor at Dubai Medical College.
He has initiated a cardiac rehabilitation program & echo-on-line projects which are among departmental quality improvement projects.
His specialty interests are ischemic heart disease, hypertension management, cardiac non-invasive diagnostic procedure, and preventive cardiology.
Dr. Gabroun is very active in teaching and research and has several publications to his name. Has made several presentations in national and international meetings and published research articles in peer-reviewed journals. His interests further extend to quality management and health care accreditation.
Dr. Atallah received his PharmD from Bernard J. Dunn School of Pharmacy in Virginia and completed an ASHP accredited post-graduate residency at Winchester Medical Center in Virginia. Dr. Atallah is board certified in pharmacotherapy with added qualifications in Cardiology. He also holds an advanced antithrombotic management certificate from the American Society of Health-System Pharmacists. Dr. Atallah is the Heart Failure Society of America (HFSA) fellow and Middle East Ambassador. He is a member of the American College of Cardiology. He also serves on the Health Authority Abu Dhabi (HAAD) subject matter experts (SME) pharmacology committee and the Emirates Heart Failure Conference Scientific Committee. He has several publications and presentations at national and international conferences.
In his current role at Cleveland Clinic Abu Dhabi, Dr. Atallah established the first per-protocol physician-pharmacotherapy specialist heart failure collaborative practice agreement clinic in the Middle-East Gulf region.
Dr. Alsindi moved to Boston, USA, where he completed his Internal Medicine Residency Program at Lahey Hospital and Medical Center. He then became the Chief of Residents and worked as an Internist at The Lahey Hospital. He later completed his Cardiovascular Fellowship at Lahey Hospital & Medical Center.
Dr. Alsindi is American Board Certified (ABIM) in Internal Medicine and Cardiovascular Medicine. He is a Fellow of The American College of Cardiology (FACC). He holds the National Echo Boards, USA. He is also a Fellow of The Royal College of Physician in Edinburgh (FRCP Edin). Additionally, he is European Board Certified in Heart Failure and has attained European Certification in HFA, and a Fellow of the Heart Failure Association, European Society of Cardiology (FHFA).
He became a Consultant Cardiologist at East Maine Medical Center, ME, USA. He was a member of the Heart Failure Team and Center of Excellence. Dr. Alsindi has attained various leadership roles at the Hospital. He became the Director of the Lipid Clinic. He also became the Director of the Cardiac Rehab Unit.
Dr. Alsindi’s academic career included several publications in peer-reviewed journals. He is also an active member of the medical education community. He has attained several teaching awards including the Award of Excellence in Medical Student Teaching, Senior Class of Tufts University School of Medicine Award for Excellence, The Gold Humanism and Excellence in Teaching Award, 19th Annual Fellow of the Year Award, Tufts Medical Student Teaching Citation Award, 20th Annual Fellow of the Year Award.
Dr. Alsindi is currently working as a Consultant Heart Failure Cardiologist at the Mohamed Bin Khalifa Cardiac Center, which is the national referral center in the Kingdom of Bahrain.
Dr. Firas Al Badarin, MD, is a Staff Physician in the Heart and vascular institute at Cleveland Clinic Abu Dhabi. Prior to joining Cleveland Clinic Abu Dhabi, Dr. Al Badarin was an Invasive Cardiologist at Prairie Heart Institute of Southern Illinois.
Dr. Al Badarin received his medical degree from the University of Jordan in Amman, Jordan and completed his Internal Medicine residency at Henry Ford Hospital/ Wayne State University, Detroit, MI, USA. Afterwards, he completed his training in General Cardiology and Cardiac Imaging at the University of Missouri, Kansas City/ Saint Luke’s Mid America Heart Institute, Kansas City, MO, USA. He also completed a Cardiovascular Outcomes Research fellowship and received a master’s degree in Clinical Bioinformatics/Clinical Research Focus from the School of Medicine, Department of Health and Bioinformatics, University of Missouri, Kansas City, Kansas City, MO, USA.
During his training, Dr. Al Badarin developed special interest in various non-invasive imaging modalities, especially radionuclide cardiac imaging (also known as, nuclear cardiology), including Positron Emission Tomography (PET), Cardiac Computed Tomographic Angiography (CCTA). He also became particularly passionate about understanding how different imaging technologies can be used to improve the efficiency of care for patients suspected to have coronary artery disease. He has published several peer-reviewed articles on how information from non-invasive imaging can be used to optimize outcomes and quality of life for patients.
Dr. Al Badarin resides in Abu Dhabi with his wife and two boys. He enjoys spending time with his family on activities, including swimming, playing soccer and biking. During his free time, he likes to play tennis and read books on self-improvement and meteorology.
He was a member of the Royal College of Physician in 2002( MRCP UK), the American national board of echocardiography in 2005, and the European accreditation in interventional cardiac pacing and defibrillators in 2007.
He was elected as a fellow of the American college of cardiology ( FACC), a fellow of the American society of echocardiography (FASE), and a fellow of the Gulf heart association (FGHA).
He has many publications in the field of echocardiography and cardiac device therapy.
A native of Palestine, Dr. Almuti moved to the United States to pursue his college and professional studies, starting his undergraduate work at the University of California at Berkeley followed by a degree in Pharmacy with Honors from the University of Texas at Austin. He pursued his medical degree at the State University of New York, followed by specialty training in Internal Medicine at the Albert Einstein College of Medicine in New York City. This was followed by training in advanced heart failure and cardiac transplantation at Columbia University Medical Center, also in New York City. He completed further training in cardiovascular disease at the Albert Einstein Medical Center and in clinical cardiac electrophysiology at the Lankenau Medical Center both in Philadelphia, Pennsylvania.
Before joining Cleveland Clinic Abu Dhabi, Dr. Almuti was a staff cardiologist and electrophysiologist at the University Of Cincinnati Medical Center in Cincinnati, Ohio. He also served as Assistant Professor of Clinical Medicine at the University of Cincinnati and as Director of Electrophysiology Services at the West Chester Hospital.
Dr. Almuti’s research has focused on the diagnosis and treatment of heart rhythm disturbances. This includes improving the safety and efficacy of cardiac ablation procedures, prevention of sudden cardiac death, prevention of stroke and related conditions, novel approaches to ablation of atrial fibrillation and ventricular arrhythmias, pharmacologic management of atrial fibrillation with antiarrhythmic drugs, and novel approaches to implantation of biventricular pacing devices. He has authored multiple articles and textbook chapters on these and other related topics.
Dr. Al Muti is a Fellow of the Heart Rhythm Society (FHRS) and the American College of cardiology.
She served as Chief Medical Resident at Henry Ford Hospital for one year following her Internal Medicine training.
She then moved on to Louisville, Kentucky where she joined Baptist Health system and enjoyed both inpatient and outpatient Endocrinology for 6 years. She was heavily involved in physician education and establishing lecture series entitled “ diabetes for the primary care physician”.
She currently is a consultant Endocrinologist at Imperial College London Diabetes Centre (ICLDC) in Abu Dhabi where she has been practicing for 6 years. She has been an integral member of the insulin pump clinic where she cares for patients with type 1 diabetes and incorporates technology to provide the best possible care for these patients.
Dr Yassine continues to wear the hat of “medical educator” and loves passing on her knowledge in providing multiple lectures to the general practitioners in the UAE.
He then became a consultant cardiologist at the University Hospital of North Durham in the UK for 15 years till April 2016. Subsequently, he moved to Saudi Arabia for 2 years and served as a consultant cardiologist in Dr. Suleiman al Habib in Riyadh. In 2008, he moved to UAE and worked as a consultant cardiologist in Al Ain Hospital as the Head of the noninvasive department and established a new multidisciplinary heart failure service. Since July of 2020, he is practicing in Tawam Hospital where he is in the process of starting a new Heart failure service.
He has a proven record of positive and significant achievements throughout the years of medical career; comprehensive and in-depth experience gathered in the national health services at teaching hospitals in the United Kingdom. He has a vast experience in practicing evidence-based cardiology service running coronary care units and cardiac wards looking after patients with acute coronary syndromes, heart failure, and arrhythmias. He is an expert in developing pathways for the management of chest pain, palpitations, and breathlessness.
He was the principal investigator for several industry sponsored international studies including ASSENT, FINESSE, TRIOLOGY, EMMACE3, PARADIGM, PARAGON, ROSE, THEMIS, LIFELIVE, and HOT trial.
Dr. El Kadri obtained his medical degree from the University of Aleppo, Syria, and then moved to the UK for postgraduate medical training. He holds a Master’s degree in Cardiology from the University of Brighton and a Ph.D. in cellular electrophysiology from the University of Liverpool. He completed his cardiology and electrophysiology training fellowships at Liverpool Heart and Chest Hospital in 2012 and spent a further 2 years of advanced ablation fellowship at the University of Michigan, USA. He practiced as a consultant cardiologist/electrophysiologist at Liverpool Heart and Chest Hospital until he moved to Abu Dhabi in 2016.
He has a special interest in the mapping and ablation of complex atrial and ventricular arrhythmias as well as complex cardiac devices management such as lead extractions. He has a special interest in education and training and is a core faculty for the ACGME-I accredited cardiology fellowship program at SKMC. He is also keen on research and has an interest in translational cardiac research and has several collaborations both at the national and international levels.
She is involved in undergraduate and graduate education and training. Her interest in graduate teaching has centered around the membership examination of the Royal Colleges of Physicians of the UK and she has been the chief organizer for the PACES (clinical) examination of the Royal Colleges of Physicians of the UK, which is held in Dubai three times yearly.
She established the Heart Failure Clinic and Anticoagulation Clinic in Dubai Hospital. She has received numerous awards for her extensive activities in UAE. She has been involved in several local and international research activities and has published her papers in several regional and international journals.
She is a Board Member of the World Heart Federation. She has extensive cooperation with the World Heart Federation and other international cardiac societies for continuous medical education in cardiology at local and international levels in the United Arab Emirates as well as regular public awareness campaigns for the prevention of cardiac disease.
Dr. Harb is listed on the Cardiology Specialist Register of the General Medical Council, U.K., with a full license to practice in the UK. He is a full-time Consultant Cardiologist at the Cure Medical Centers in Abu Dhabi, UAE.
Dr. Bafadel was trained in internal medicine at Toronto General Hospital, Toronto, Ontario, Canada. He completed his cardiology fellowship at Libin Cardiovascular Institute in Calgary, Alberta, Canada. After, Dr. Bafadel worked as a teaching faculty and a cardiologist at King Saud Medical School, in Saudi Arabia, where he was involved in a cardiology fellowship program for training cardiology specialists. He moved after to the United State to get the experience of advanced cardiovascular imaging at the Heart & Vascular Institute at Cleveland Clinic, Ohio, USA where he was trained in structural 3D Echocardiography guidance of percutaneous valve implantation, Nuclear Cardiac Imaging, and Cardiovascular CT. His research on transesophageal echocardiography (TEE) and nuclear cardiology has been presented in international cardiac conferences.
Dr. Bafadel is board certified by both the Royal College of Physicians of Canada (FRCPC) and the American Board of Internal Medicine (ABIM) in cardiovascular disease, as well as internal medicine. He also holds board certifications for cardiac multimodality imaging including echocardiography, nuclear cardiology, and cardiac CT.
He has done his Post Doctorate in Cardiology from University of Bombay and Cardiology Fellowship from Melbourne, Australia. He is an Elevated Fellow of Royal College of Physicians of Glasgow and Edinburg. He has long experience as Consultant in Cardiology in India, Saudi Arabia and UAE.
He is involved in research work and has authored many publications which have been published in peer reviewed journals such as European Heart Journal. He has also authored many chapters in textbooks. He is the Principal investigator for many international registries at the Middle East and Global levels including FLOW, CEPHEUS, GULF RACE, GULF ACS, and GARFIELD Registries. He is a member of Committee of Emirates Cardiac Society in Imaging as well as Preventive Cardiology. He has vast clinical experience with special interest in Echocardiography, Hypertension, Valvular Heart Disease and Preventive Cardiology on which is given many state of Art lectures across the world and is a regular faculty in ACC and ESC meetings. He is a teacher and an examiner for undergraduate and post graduate level in India and UAE. He is also the chair of widely attended Annual Fujairah Cardiovascular Symposium.
She has also worked as and a lecturer of Cardiology and Angiology at the Faculty of Medicine, Alexandria University, and is a teacher of Clinical Cardiology for under- and post-graduates at United Arab Emirates University.
She has performed almost 40,000 transthoracic echocardiography cases and is a 1ry operator in transoesophageal echocardiography and dobutamine stress echocardiography.
She performs all non-invasive cardiology procedures including stress electrocardiography, ambulatory blood pressure monitoring, and Holter’s 24-hour monitoring, in addition to elective cardioversion.
She is a member of the Egyptian Society of Cardiology, the European Society of Cardiology, and Emirates Society of Cardiology.
After graduating from the University of Jordan School of Medicine in 1998, he finished Internal Medicine Residency as well as Heart Failure and Transplant Fellowship within the Yale University School of Medicine system. In 2003, he went to the University of Utah and completed his Cardiovascular Fellowship in 2006. Upon completion of his fellowship, he joined the faculty there at the Division of Cardiology. He served as the Medical Director of the Heart Failure Program at the University of Utah Hospital and the Director of the Advanced Heart Failure and Transplant Fellowship Program. During his time there, he also obtained a Master’s Degree in Clinical Investigation.
In 2015, Dr. Bader joined the Cleveland Clinic in Abu Dhabi to pursue his ambition of building an internationally recognized advanced heart failure and transplant program in the Middle East. There, he established the first multidisciplinary heart failure and transplant program of its kind in the country and one of very few in the Middle East that can offer the full spectrum of therapies including artificial heart pumps and heart transplants.
Dr. Bader is American Board certified in Internal Medicine, Cardiovascular Diseases, Echocardiography, and Advanced Heart Failure and Transplant Cardiology. His research interests include various aspects in ventricular assist devices, hemodynamics, and cardiorenal interaction in heart failure. He has participated in many single and multi-center trials and has published several articles in peer-review journals. He is a Fellow of the American College of Cardiology. <br /><br />
Dr. Bader is the Chairman of the Heart Failure Working Group of the Emirates Cardiac Society. He is also the Co-Chairman of the International Heart Failure Working Group of the American College of Cardiology on behalf of the Middle East region, and the Ambassador for the Heart Failure Society of America to the Middle East.
Dr. Al Mansoori graduated with distinction in Medicine and Surgery from Dubai Medical College and obtained her Masters’ degree in Clinical Cardiac Pharmacology from the University of Aberdeen. Following her residencies training in Internal medicine and Adult Cardiology at the University of Toronto-Canada, Dr. Ghadeera Al Mansoori found her niche in Congenital and Genetic Heart disease, she pursued dual fellowships in Adult Congenital Heart Disease and Hypertrophic Cardiomyopathy at the Toronto Congenital Cardiac Center and Hypertrophic Cardiomyopathy Program, Toronto General Hospital, University Health Network, The University of Toronto.
Dr. Al Mansoori is a Fellow of the Royal College of Physicians and Surgeons of Canada and Royal College of Physicians UK and a Diplomate of the American Board of Internal Medicine.
He earned his Bachelor of Medicine and Bachelor of Surgery from Marmara University, Istanbul.
With 31 years of rich and insightful experience and a doctorate in Cardio-vascular Medicine, Dr. Salah is serving as a Head of the Cardiology unit in Kalba Hospital, UAE.
Some of his past work experiences include Professor of Cardiology at Suez Canal University in Egypt, Cardiology Consultant at King Faisal Specialist Hospital in Saudi Arabia, and Invasive Cardiology Fellow at the Rennes University in France.
He specializes in the end-to-end treatment of Coronary Care Unit patients, out-patient cardiology consultations, treatment of cardiac ward in-patients, and care of post-surgical patients. He has independently performed innumerable echocardiograms (Dobutamine stress echo, Trans Thoracic Echocardiography and TEE (Trans-esophageal echocardiography), and Holter Studies.
He has actively contributed to extensive research in cardiology, deep expertise in this field and skills have earned immense recognition and respect from reputed Healthcare Institutions, Peers & Patients.
He has served as a Principal Investigator in several trials including GLORIA – AF, COMPLETE TRIAL ON IHD (ACUTE MI), REPORT-HEART FAILURE PROJECT, and EURO ACUTE ACS.
He is currently serving as the Chair of Cardiac Institue in Sheikh Khalifa Medical City in UAE.
Before joining Cleveland Clinic Abu Dhabi, Dr. Shantouf was a Health Sciences Assistant Clinical Professor of Medicine at David Geffen School of Medicine at UCLA, where he has served as the Director of the Cardiac Catheterization lab of Olive View-UCLA Medical Center since 2016. He further served as the Cardiology Education Course Chair for the Olive View-UCLA Internal Medicine Residency program. As an Interventionalist, he specializes in trans-radial coronary interventions, intravascular imaging, and invasive hemodynamic assessment. He has also performed thousands of cardiac catheterizations throughout his career.
Dr. Shantouf is American Board certified. He received his medical degree from the University of California in Los Angeles (UCLA) and went on to complete his residency in Internal Medicine at the UCLA Medical Center.
Dr. Shantouf enjoys spending his free time with his wife and son. When not at work, he enjoys playing the guitar, listening to music, discovering new travel destinations, and reading.
Dr. Bakir is a Fellow of the American College of Cardiology (FACC) and member of a numerous Societies of Cardiology.
He has authored and co-authored numerous publications which have appeared in peer-reviewed journals. He has received widespread recognition for his achievements especially in the field of continuous medical education (CME), and he was named in the Who’s Who in America, Medicine and Healthcare, Who’s Who in America, Science and Engineering, Who’s Who in America, The Barons 500 Leaders for the New Century, Barons Who’s Who (USA), and Outstanding People of the 20th Century, Incorporating the outstanding Achievement Awards, International Biographical Center Cambridge, England. He was also Nominated the best speaker of the year for HAAD CME Program, Health Authority-Abu Dhabi, CME/CPD Annual Award Ceremony 2010.
Dr. Bakir has served as an investigator on clinical trials in cardiovascular medicine.
He graduated from GSVM Medical College, Kanpur, India. After earning his post-graduation, he moved on to complete his postdoctoral training in cardiology. He completed level III training in cardiac CT from Harbour hospital, UCLA. He is Board Certified in cardiovascular CT and has accreditation by SCCT, USA. He is a fellow of the American College of Cardiology.
He has been an associate professor of cardiology at Sri Venkateswara Institute of Medical Sciences, Tirupati, India, and a visiting consultant to Indraprastha Apollo Hospital, New Delhi.
His areas of interest are complex coronary interventions, coronary imaging and physiology, and cardiac CT. Dr. Agarwal regularly participates as a course faculty in national and international meetings like Euro PCR, TCT, and cardioAlex. He has published research articles in peer-reviewed journals on antiplatelet therapy, thrombolytic therapy, and recently on COVID-19.
Some of his past work experiences include Senior Consultant Cardiologist at Dr. Sulaiman Al Habib Group and Chairman of Cardiac Center at Specialized Medical Center Hospital in Riyadh and Chief of Cardiology at Zulekha Hospital in Sharjah.
He earned his MD from Damascus University in 1985. He obtained his residency training in Internal Medicine from Georgetown University, followed by a fellowship in Interventional Cardiology, Cardiovascular Medicine, and Cardiac Devices and Electrophysiology from the Havard Medical School.
His clinical specialties are Interventional Cardiology, Clinical Electrophysiology, Epidemiology, Cardiac Devices, Oncology, Clinical Data Management, and Good Clinical Practice (GCP).